Neudle.com: multiple sclerosis cost of

Differential
(Click to cross reference)

abdominal reflex, absent

acetylcholine receptor

acetylcholine receptor antibody

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

alemtuzumab

algorithm

amphiphysin antibodies

amyotrophic lateral sclerosis

ANA

angiotensin-converting enzyme

anti MAG antibodies

anti Ro antibody

area postrema

area postrema syndrome

basal ganglia, lesion of

CAT scan, emission, abnormal

CAT scan, indications for

central nervous system, infection of

cerebral edema, vasogenic

cerebral peduncle

cerebral vasculature

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, oligoclonal bands, absent

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, mimics

cervical spine manipulation

children

chiropractic manipulation

chorioretinitis

cladribine

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

controversies in neurology

conversion reaction

cop 1

corpus callosum

corpus callosum, lesion of

cytomegalovirus infection

demyelinating disease

dermatomyositis

diagnostic criteria

diencephalon

differential diagnosis

diplopia

disability, neurological

disease modifying agents

electroencephalogram, abnormalities of

embolism

embolism, cholesterol

employment

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

epidemiology of neurology

evidence-based research

fourth ventricle, floor

fumarate

gadolinium

gag reflex, depressed

gammaglobulin therapy, intravenous

gender

gray matter

Guillain Barre syndrome

heralding manifestation

herpes zoster

hiccoughs

hiccoughs, intractable

hyponatremia with cerebral disorders

hypothalamus

hypothalamus, damage to

hypothalamus, lesion of

hypothermia

iatrogenic neurologic disorders

idiopathic

immunohistochemistry

immunology and the nervous system

immunomodulation

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inclusion body myositis

inebilizumab

infection

infliximab

intellectual deterioration

intracerebral hemorrhage

lesions too numerous to count

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

level of consciousness, decreased

limbic encephalitis

linear lesion

lipoprotein receptor-related protein 4

lumbar spine manipulation

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

mammillary bodies

managed care

marihuana

McDonald criteria for MS

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

meningeal enhancement

mental status, abnormal

mesial temporal sclerosis

methotrexate

microangiopathy, spinal cord

microemboli

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

migraine

migraine, cost of

migraine, treatment of

mimics

misdiagnosis

mitoxantrone

monoclonal antibodies

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, field strength, high

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, susceptibility weighted

MRI, target sign

MRS

multiple sclerosis

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, epidemiology of

multiple sclerosis, late-onset

multiple sclerosis, lesion location

multiple sclerosis, misdiagnosis

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, tumefactive

multiple sclerosis, without CSF bands

multiple sclerosis, work up for

multiple system atrophy

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

myelitis, longitudinal

myelitis, post infectious

myelitis, transverse

myelitis, transverse, idiopathic

myelitis, transverse, prognosis

myelitis, transverse, recurrent

myelopathy, necrotizing

myocarditis

myofascial pain syndrome

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, systemic cancer

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic evaluation

neurologic symptoms, unexplained

neurology clinic

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica (Devic's disease), screening

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, peripheral, treatment

neuroradiology

NMDA antagonists

Oculinum

old age, neurology of

ophthalmoplegia

opportunistic infection

optic chiasm

optic chiasm, lesion of

optic nerve

optic nerve, enhancement

optic nerve, lesion of

optic neuritis

optic neuritis, alternating

optic neuritis, bilateral

optic neuritis, recurrent

optic neuropathy

optic neuropathy, ischemic

optical coherence tomography

outcome research

ovarian tumor

owl's eye sign of spinal cord

Parkinsonism syndrome

pathology

patient information and support

periaqueductal lesion

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

rehabilitation for neurologic disorders

remission

remote effect of cancer on the nervous system

respirator

respiratory failure

retinal lesion

reversible neurologic disorder

review article

risk factors

risk-benefit assessment

scleroderma, neurologic involvement with

screening

sedimentation rate, elevated

seizure

seizure, intractable

seizure, intractable, treatment of

seizure, surgical treatment of

seizure, treatment of

sensory level

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

seronegative

seropositive

shared decision making

single photon emission computed tomography

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

somnolence

spasticity

spasticity, treatment of

spinal cord

spinal cord, biopsy

spinal cord, compression of

spinal cord, dorsal subpial enhancement

spinal cord, enlargement

spinal cord, infarction of

spinal cord, lesion of

spinal cord, neoplasm

splenium of corpus callosum

sprain, cervical

sprain, cervical-treatment of

staphylococcal protein A column therapy

steroid

steroid therapy, CNS treatment and complications with

stiff man syndrome

strain, back

subarachnoid hemorrhage

sumatriptan

sweet taste

symmetric brain lesions

syringomyelia

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

tender points

teriflunomide

thalamus, lesion of

thalamus, lesion of-bilateral

third ventricle, wall

transient neurologic deficit

trauma

treatment of neurologic disorder

tuberculosis

tumefactive lesion

ultrasonography

ultrasonography, carotid artery

vision loss, sequential

vision, blurred

visual acuity

visual evoked response

visual loss

visual loss, progressive

visual loss, sudden

vomiting, intractable

Wallerian degeneration

water channel antibodies

weakness

weakness, acute

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter disease

white matter disease, periventricular

whites

work loss

workers' compensation

workup

Showing articles 950 to 1000 of 4442 << Previous Next >>

Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997

Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997

Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997

Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997

Idiopathic Granulomatous Angiitis of the CNS Manifesting as Diffuse White Matter Disease
Neurol 49:1696-1699, Finelli,P.F.,et al, 1997

The 5-Year Risk of MS After Optic Neuritis
Experience of the Optic Neuritis Trtm Trial, Optic Neuritis Study Group, Neurol 49:1404-1413997., , 1997

Risk Factors for Developing Multiple Sclerosis after Childhood Optic Neuritis
Neurol 49:11413-1418, Lucchinetti,C.F.,et al, 1997

Cerebral Manifestation of Erdheim-Chester Disease:Clinical and Radiologic Findings
Neurol 49:1702-1705, Bohlega,S.,et al, 1997

Echocardiographic Identif of Cardiovascular Sources of Emboli to Guide Clin Manag of Stroke:Cost-Effec Analysis
Ann Int Med 127:775-787, McNamara,R.L.,et al, 1997

A Case-Control and Nerve Biopsy Study of CREST Mutliple Mononeuropathy
Neurol 49:1641-1645, Dyck,P.J.B.,et al, 1997

Myocardial Ischemia with Normal Coronary Arteries Associated with Thoracic Myelitis
NEJM 337:1920, Lalouschek,W.,et al, 1997

Trigeminal Neuralgia in Patients with Multiple Sclerosis:Lesion Localization with magnetic Resonance Imaging
Neurol 49:1142-1144, Gass,A.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997

Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997

Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997

Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997

Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997

Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997

Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997

Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997

The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997

Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997

Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997

Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997

Longitudinal Change in Basal Ganglia Volume in Patients with Huntington's Disease
Neurol 48:394-399, Aylward,E.H.,et al, 1997

Medial Temporal Lobe Volumetrics in Traumatic Brain Injury
AJNR 18:25-28, Jack,C.R.,et al, 1997

Multiple Sclerosis Presenting as Transverse Myelopathy:Clinical and MRI Features
Neurol 48:65-73, Simnad,V.I.,et al, 1997

Volumetric MRI Analysis Comparing Subjects Having Attention-Deficit Hyperactivity Disorder with Normal Controls
Neurol 48:589-601, Filipek,P.A.,et al, 1997

Neuroanatomy in Rett Syndrome:Cerebral Cortex and Posterior Fossa
Neurol 48:399-407, Subramaniam,B.,et al, 1997

Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997

Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997

Paramedian Pontine Infarction
Stroke 28:809-815, Kataoka,S.,et al, 1997

Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997

A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997

Quality of Life Among Persons with Multiple Sclerosis and Their Caregivers
Neurol 48:74-80, Aronson,K.J., 1997

Improving Interobserver Variation in Reporting Gadolinium-Enhancing MRI Lesions in Multiple Sclerosis
Neurol 49:1682-1688, Barkhof,F.,et al, 1997

Showing articles 950 to 1000 of 4442 << Previous Next >>